Skip to main content

Table 4 Serum lipid concentrations during the study

From: Supplementation of krill oil with high phospholipid content increases sum of EPA and DHA in erythrocytes compared with low phospholipid krill oil

Parameters (mMol/L) Treatment Baseline Endpoint Change (Difference)
TG HPL Krill oil 98.02 ± 11.76 94.90 ± 9.25b −3.12 ± 5.50
LPL krill oil 106.2 ± 9.62 101.21 ± 10.41 −4.99 ± 4.74
Control 99.91 ± 10.02 101.51 ± 10.93 1.60 ± 4.78
HDL HPL Krill oil 54.52 ± 3.14 59.36 ± 3.25 4.84 ± 1.75
LPL krill oil 55.48 ± 3.33 57.81 ± 3.76 2.33 ± 1.91
Control 54.71 ± 3.02 56.65 ± 2.90 1.94 ± 1.12
LDL HPL Krill oil 94.28 ± 5.47 101.52 ± 7.00a 7.25 ± 3.67a
LPL krill oil 96.93 ± 7.25 100.32 ± 8.27a 3.40 ± 3.35
Control 93.89 ± 5.07 92.30 ± 5.70 −1.60 ± 2.79
TC HPL Krill oil 168.02 ± 6.26 179.61 ± 7.65a 11.59 ± 4.19a
LPL krill oil 173.62 ± 7.06 177.68 ± 9.18 4.06 ± 4.76
Control 169.56 ± 5.53 169.56 ± 6.06 0.00 ± 3.62
TC/HDL HPL Krill oil 3.28 ± 0.23 3.22 ± 0.26 1.50 ± 0.42
LPL krill oil 3.41 ± 0.31 3.34 ± 0.30 1.93 ± 0.58
Control 3.32 ± 0.22 3.21 ± 0.23 1.96 ± 0.74
  1. Values are expressed as Mean ± SEM. n = 20. a and b denote significance compared with control and LPL respectively. TG- triglycerides, HDL high density lipoprotein, LDL low density lipoprotein, TC total cholesterol